Search research articles
Contact Us
Filters
Showing results (1-10 of 143) with videos related to
Page
of 15
Sort By:
Current Opinion in HIV and AIDS
|
September 15, 2023
'Immunization during ART and ATI for HIV-1 vaccine discovery/development'
Leonidas Stamatatos
Current Opinion in Immunology
|
May 19, 2012
HIV vaccine design: the neutralizing antibody conundrum
Leonidas Stamatatos
Current HIV Research
|
February 24, 2025
The Germline Targeting Vaccine Concept: Overview and Updates from HIV Pre-Clinical and Clinical Trials
Leonidas Stamatatos
Journal of Virology
|
July 28, 2010
Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop
Lance Ching, Leonidas Stamatatos
Plos One
|
November 16, 2012
Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject
Iliyana Mikell, Leonidas Stamatatos
Journal of Virology
|
June 5, 2009
Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotype
Aaron Wallace, Leonidas Stamatatos
Vaccine
|
June 1, 2010
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
D Noah Sather, Leonidas Stamatatos
Immunity
|
November 21, 2015
Common Characteristics of HIV-Neutralizing Antibodies with a Fondness for Sugars
Andrew T McGuire, Leonidas Stamatatos
Current HIV Research
|
November 30, 2007
Prospects of HIV Env modification as an approach to HIV vaccine design
Shiu-Lok Hu, Leonidas Stamatatos
AIDS (London, England)
|
April 15, 2004
Role of neutralizing antibodies in HIV infection
Nancy L Haigwood, Leonidas Stamatatos
Page
of 15
Search research articles
Search
Showing results (1-10 of 143) with videos related to
Sort By:
Page
of 15
Current Opinion in HIV and AIDS
|
September 15, 2023
'Immunization during ART and ATI for HIV-1 vaccine discovery/development'
Leonidas Stamatatos
Current Opinion in Immunology
|
May 19, 2012
HIV vaccine design: the neutralizing antibody conundrum
Leonidas Stamatatos
Current HIV Research
|
February 24, 2025
The Germline Targeting Vaccine Concept: Overview and Updates from HIV Pre-Clinical and Clinical Trials
Leonidas Stamatatos
Journal of Virology
|
July 28, 2010
Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop
Lance Ching, Leonidas Stamatatos
Plos One
|
November 16, 2012
Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject
Iliyana Mikell, Leonidas Stamatatos
Journal of Virology
|
June 5, 2009
Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotype
Aaron Wallace, Leonidas Stamatatos
Vaccine
|
June 1, 2010
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
D Noah Sather, Leonidas Stamatatos
Immunity
|
November 21, 2015
Common Characteristics of HIV-Neutralizing Antibodies with a Fondness for Sugars
Andrew T McGuire, Leonidas Stamatatos
Current HIV Research
|
November 30, 2007
Prospects of HIV Env modification as an approach to HIV vaccine design
Shiu-Lok Hu, Leonidas Stamatatos
AIDS (London, England)
|
April 15, 2004
Role of neutralizing antibodies in HIV infection
Nancy L Haigwood, Leonidas Stamatatos
Page
of 15